Investment House LLC raised its position in Henry Schein, Inc. (NASDAQ:HSIC) by 101.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 46,650 shares of the company’s stock after buying an additional 23,540 shares during the quarter. Investment House LLC’s holdings in Henry Schein were worth $3,825,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. YorkBridge Wealth Partners LLC lifted its stake in Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after buying an additional 28 shares during the last quarter. Sun Life Financial INC lifted its stake in Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after buying an additional 573 shares during the last quarter. Lee Financial Co purchased a new stake in Henry Schein in the second quarter valued at approximately $161,000. Acrospire Investment Management LLC lifted its stake in Henry Schein by 150.0% in the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock valued at $183,000 after buying an additional 600 shares during the last quarter. Finally, HM Payson & Co. purchased a new stake in Henry Schein in the second quarter valued at approximately $204,000. Institutional investors own 47.48% of the company’s stock.
Henry Schein, Inc. (HSIC) traded down 0.83% during midday trading on Wednesday, hitting $77.95. The stock had a trading volume of 862,424 shares. The stock has a 50-day moving average price of $81.28 and a 200 day moving average price of $87.09. The firm has a market cap of $12.32 billion, a PE ratio of 22.78 and a beta of 1.08. Henry Schein, Inc. has a one year low of $73.61 and a one year high of $93.50.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 8th. The company reported $0.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.86 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The business had revenue of $3.06 billion during the quarter, compared to analyst estimates of $3.05 billion. During the same quarter in the previous year, the firm posted $0.82 EPS. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, analysts predict that Henry Schein, Inc. will post $3.64 earnings per share for the current year.
Henry Schein announced that its Board of Directors has authorized a stock repurchase plan on Monday, September 18th that allows the company to buyback $400.00 million in outstanding shares. This buyback authorization allows the company to buy up to 6.3% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s board of directors believes its shares are undervalued.
In related news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the transaction, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.19% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Investment House LLC Raises Holdings in Henry Schein, Inc. (HSIC)” was reported by Community Financial News and is the property of of Community Financial News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.com-unik.info/2017/11/01/investment-house-llc-raises-holdings-in-henry-schein-inc-hsic.html.
A number of equities research analysts have weighed in on the company. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price objective for the company in a research note on Monday, August 7th. BidaskClub cut Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. Jefferies Group LLC reiterated a “hold” rating and issued a $89.00 price objective on shares of Henry Schein in a research note on Friday, October 20th. Finally, Credit Suisse Group reiterated a “hold” rating and issued a $80.00 price objective on shares of Henry Schein in a research note on Thursday, July 13th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and six have given a buy rating to the company’s stock. Henry Schein presently has a consensus rating of “Hold” and an average target price of $92.89.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
What are top analysts saying about Henry Schein Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Henry Schein Inc. and related companies.